ArticleJournal of Cancer2022

Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in Korea.

Seung-Hoon Beom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.